PROCEDURE · Unmapped registry intervention
PET scan with injection of 5-8 mCi of 18FES
Find medicine records ·
Find other trials using this name
Clinical trial
Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer
NCT00647790
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPositron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
United States Department of Defensecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00647790 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.